MYX 3.89% $4.45 mayne pharma group limited

Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook, page-19

  1. 1,707 Posts.
    lightbulb Created with Sketch. 169
    EBITDA flat is certainly an improvement but can that figure be trusted if >$50m of cash was burnt in the quarter?
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.